New Data Highlights the Efficacy of the Merlin CP-GEP Test for T1a Melanomas
Click to view the templateTotal Sent
17541
Deliveries
17428
(99.36%)
Unsubscribe
0.07%
12
Clicks
3.04%
533 (3.04%)
Open Rate
3603
Bounces: 113(
0.64%)
Forwards: (0.00%)
CTOR: (15.00%)
0.09%
Late Breaking: Largest Prospective Melanoma GEP Trial
Click to view the templateTotal Sent
17416
Deliveries
17396
(99.89%)
Unsubscribe
0.03%
5
Clicks
3.28%
572 (3.28%)
Open Rate
3712
Bounces: 20(
0.11%)
Forwards: (0.00%)
CTOR: (15.00%)
0.09%